MedPath

Radiofrequency Non-ablative in the Treatment of Genitourinary Syndrome of Menopause

Not Applicable
Recruiting
Conditions
Genitourinary Syndrome of Menopause
Interventions
Device: Radiofrequency non ablative
Registration Number
NCT03506594
Lead Sponsor
Centro de Atenção ao Assoalho Pélvico
Brief Summary

The study is conducted in women at the menopause with a clinical diagnosis of Genitourinary Syndrome, which presents symptoms in of vulvovaginal atrophy and tract urinary and were treated with radiofrequency non ablative technique for capacitive transfer in intra-vaginal. All participants were evaluated by a physical therapist and did the exam of PH vaginal, cell maturation index and questionnaires. The participants made five sessions of Radio Frequency (RF) with an interval of seven days between them. The application of RF was performed by physical therapist trained in the technique of radio frequency through the Capenergie brand device with capacitive transfer method using non-ablative handle with active electrode intra-vaginal and coupling electrode placed on the participant's back. For application, the participants were in gynecological position. The session had an average duration above 20 minutes. The temperature was measured by an infrared thermometer when it reached 41graus radiofrequency was maintained for 2 minutes in the anterior wall and 2 minutes more in the posterior wall of vagina.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
Female
Target Recruitment
58
Inclusion Criteria
  • will be women in menopause until 65 years of age with clinical complaints of Genitourinary Syndrome of Menopause and who agree to voluntarily participate in the research.
Exclusion Criteria
  • will be excluded from the study participants with limited understanding, with neurological degenerative chronic diseases, sensory deficit in the genital region, users of pacemaker and intrauterine device of cooper and women under hormone therapy under six months

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Radiofrequency ON and KinesiotherapyRadiofrequency non ablativeThe radiofrequency application protocol with the CAPENERGY device, which has two electrodes: an active one, which will be introduced into the vagina, using a condom and gel to the emission of radiofrequency and another electrode, dispersive, coupled to the patient's hip, which will function as earth. The temperature used in the treatment will be 41°C, which this parameter will be placed in the equipment, maintained for 2 minutes at the anterior wall and 2 others minutes at the posterior wall. Five RF sessions will be performed, with a seven-day interval between them. For the application, participants will be placed in supine position. The session will be quick, with an average duration of 20 minutes. Kinesiotherapy will be done once a week, totaling five sessions. Initially, verbal information about location, function, and the correct way to contract the pelvic floor (PA) will be given.
Radiofrequency OFF and KinesiotherapyRadiofrequency non ablativeThe patient will be in supine decubitus, the vaginal probe of the radiofrequency apparatus will be introduced, with the gel previously heated. The radiofrequency will be off. Kinesiotherapy will be done once a week, totaling five sessions. Initially, verbal information about location, function, and the correct way to contract the pelvic floor (PA) will be given.
Primary Outcome Measures
NameTimeMethod
Change in Cell maturation indexEach 3 months pos treatment, until one year

% cells parabasal, % intermediate cells and superficial cells

Change in Vaginal PHEach 3 months pos treatment, until one year

During the fertile years of life, the vaginal pH ranges from 3.5 to 4.5. At menopause, vaginal Ph increases to above 4.5. The higher the vaginal Ph, the greater the degree of atrophy

Secondary Outcome Measures
NameTimeMethod
Female Genital Self-image Scaleone week, one month, three months, six months, nine months and one year
Questionnaire of quality of life specified urinary incontinenceone week, one month, three months, six months, nine months and one year

The ICIQ-SF

Numeric Visual Scaleone week, one month, three months, six months, nine months and one year

Will be evaluated vaginal dryness, pain during intercourse, vaginal laxity, burning sensation and itching, on a scale of 0 to 10, being 0 asymptomatic and 10 the maximum of symptoms

Female Sexual Function Indexone week, one month, three months, six months, nine months and one year

FSFI

Trial Locations

Locations (1)

Centro de Atenção ao Assoalho Pelvico

🇧🇷

Salvador, Ba, Brazil

© Copyright 2025. All Rights Reserved by MedPath